Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...

A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer ...

Eli Lilly (LLY) saw notable developments in September, with the launch of Lilly TuneLab, an AI/ML platform designed to ...

The company already has injectable GLP-1 drugs that are generating billions in revenue, Despite its valuation, the stock only ...

Eli Lilly dominates obesity and diabetes treatments with soaring tirzepatide sales and promising oral drug data. Find out why ...

Eli Lilly's approved blood cancer therapy Jaypirca helped delay progression of the disease in previously untreated patients ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

Eli Lilly plans to build a massive $5.9 billion campus that could change the landscape of Northeast Houston’s Generation Park ...

Eli Lilly and Company (NYSE: LLY) is one of the stocks to invest in before they split next. On September 9, Eli Lilly and Company launched a new global campaign titled “Brain Health Matters” to ...

In fact, they have qualities that make them likely to deliver excellent returns over the long run, making them great forever ...

A $193 million award against Eli Lilly and Co. in a False Claims Act suit alleging Medicaid fraud will stand, the Seventh ...

Three Motley Fool contributors believe they've found healthcare stocks that you can buy and hold forever. Here's why they ...